Anzeige
Meldung des Tages: Milliarden aus Washington? Dieser kritische Rohstoff könnte der nächste Profiteur sein

Invesco Global Clean Energy ETF News

ETF
WKN:  A2JNUA ISIN:  US46138G8472 US-Symbol:  PBD
14,752 €
-0,074 €
-0,50%
06.11.25
Depot/Watchlist
Indexbildung
Ertragsverwendung
Thesaurierend
Lfd. Kosten
-
Fondsgröße
-  
Tracking Error
-
Währung
FWW Fundstars
keine Bewertung

Invesco Global Clean Energy ETF News

05.01.26 - PR Newswire
Protalix BioTherapeutics Letter to Stockholders
Protalix BioTherapeutics Letter to Stockholders PR Newswire
13.11.25 - PR Newswire
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results PR Newswire
14.08.25 - PR Newswire
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results PR Newswire
07.08.25 - PR Newswire
Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025
Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 PR Newswire
30.06.25 - PR Newswire
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® PR Newswire
14.05.25 - PR Newswire
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC PR Newswire
05.05.25 - PR Newswire
Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025
Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 PR Newswire
24.03.25 - PR Newswire
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 PR Newswire
17.03.25 - PR Newswire
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results PR Newswire
10.03.25 - PR Newswire
Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025
Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025 PR Newswire
04.02.25 - PR Newswire
Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference
Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference PR Newswire

Newssuche

Videos

newspaper
02.02.26 -24,26%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »